To examine the clinical relevance of this reciprocal regulatory network in neuroblastoma patients, we examined the correlations between the CDKN3, CDK4 and CDC6 mRNA levels in the above three patient datasets. This evidence concerns the gene CDC6 and neuroblastoma.